SP1 and hypertensive disorder: Moreover, SMAD family member 7 has also been discovered to inhibit AngII-mediated HTN through the Sp1/SMAD family member 3/nuclear factor kappa B (NF-κB)/miR-29b regulatory network, and it is identified as a therapeutic biomarker for AngII-mediated HTN [9].